Sudeep Pharma544619Pharmaceuticals
Sudeep Pharma reported strong EBITDA growth of around 31% year-on-year
By ScoutQuest · · 1 min read
- EBITDA growth year-on-year
- around 31 percent
Heard on business television between 08:46:59 - 08:49:59 IST.
- Pat said Sudeep Pharma's EBITDA grew pretty well, around 31% year-on-year.
Watch at source
behind live
- 1Open on YouTube
- 2Drag the seek bar left
- 3Watch this moment
Also from Sudeep Pharma
Earnings call transcript: record quarterly revenue and EBITDA, segment-wise outlook outlined
3 Nov 2026
Sudeep Pharma uploads audio recording of earnings call held 29 October 2026
29 Oct 2026
Sudeep Pharma posts record Q2 FY27: revenue up 21% to Rs 196.7 crore, EBITDA up 32%; Nandesari gets FDA nod, Dahej battery plant on track
28 Oct 2026
Source: Live TV News Channel · 29 Oct 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.